Privia Health Group, Inc. Stock Price, News & Analysis

Privia Health Group, Inc. (PRVA) is expanding its national provider network by collaborating with over 430 new providers in California and Texas. This includes partnerships with BASS Medical Group in California and Abilene Diagnostic Clinic in West Texas. These ventures aim to enhance patient care and support healthcare providers in their transition to value-based care. The company plans to update its full-year 2021 guidance following its third-quarter financial results on November 8, reflecting the anticipated impact of these expansions.

Privia Health Group (Nasdaq: PRVA) is set to announce its third-quarter financial results for the period ending September 30, 2021, before market open on November 8, 2021. The financial press release will be available at ir.priviahealth.com by 7:00 am ET. Management will also hold a conference call at 8:00 am ET to discuss the results and future outlook. Interested parties can participate via a webcast or by dialing 855-940-5315.

BOSTON--(BUSINESS WIRE)--Kyruus announced that Privia Health is now using the Kyruus ProviderMatch platform to enhance patient access and streamline online appointment bookings. Privia Health serves approximately 2,700 providers and 3 million patients, aiming to improve consumer self-service and reduce administrative burdens. The integration facilitates a seamless search experience, allowing patients to find providers based on specific needs. With online scheduling activated for nearly 1,200 providers, Privia is poised for further growth in digital offerings.

Biote Medical has announced the election of Dr. Mark Cone and Dana Jacoby to its Board of Directors, strengthening its leadership team with over 60 years of combined experience in healthcare and business management. Dr. Cone is the Market President of Privia Health in South Texas, while Jacoby has led nearly $1 billion in healthcare mergers and transactions. Their appointments aim to enhance Biote's growth and address hormone deficiencies affecting over 200 million Americans.

Privia Health Group (Nasdaq: PRVA) reported impressive results for 2020, achieving $86.5 million in shared savings through its Accountable Care Organizations (ACOs) via the Medicare Shared Savings Program (MSSP). The Privia Quality Network served over 121,000 Medicare beneficiaries, demonstrating a commitment to quality care while lowering costs. Key metrics showed that Privia's expenditures were 15% lower than the median MSSP ACO and emergency room utilization was 22% lower. Since 2014, total shared savings exceed $519 million.

Privia Health Group, Inc. (Nasdaq: PRVA) reported strong revenue growth in Q2 2021, with total revenue climbing to $225.8 million, a 23.2% increase year-over-year. However, the company faced significant operating and net losses of $193.2 million and $172.5 million, respectively, mainly due to $202.6 million in non-cash stock compensation expense related to its IPO. Excluding these, non-GAAP adjusted net income increased 69.0% to $10.4 million. The company expects continued growth with increased provider partnerships and attributed lives, revising its full-year guidance upwards.

Privia Health Group (Nasdaq: PRVA) has announced its financial results release for the second quarter ended June 30, 2021, scheduled for August 9, 2021, before market open. The financial results will be available at 7:00 am ET on the company's Investor Relations website. Additionally, a conference call will follow at 8:00 am ET the same day to discuss the results and future outlook. Interested parties can access the call via webcast or by dialing 855-940-5315.

Health Enterprise Partners (HEP) announced five realizations of portfolio companies and a new investment in Kno2, marking its tenth platform investment from HEP III. HEP focuses on founder-financed businesses, having previously invested in Twistle, which enhances patient engagement in healthcare. Health Catalyst (NASDAQ: HCAT) disclosed its acquisition of Twistle, enhancing its data and analytics services. Privia Health (NASDAQ: PRVA) completed a successful IPO, raising approximately $131.7 million. HEP's new investment in Kno2 will support interoperability in healthcare, aiming for better patient information exchange.

Privia Health Group, Inc. (Nasdaq: PRVA) has appointed Dr. Jaewon Ryu to its Board of Directors, expanding the board to nine members. This strategic move aims to leverage Dr. Ryu’s extensive experience in value-based reimbursement and patient care management to support the company's growth across the U.S. Dr. Ryu is currently the President and CEO of Geisinger and has held various leadership roles in healthcare. The board believes his expertise will significantly benefit Privia Health's initiatives in enhancing patient experiences and delivering high-value care.